Anaemia Intermediate Cycle II HLTM

Embed Size (px)

Citation preview

  • 8/3/2019 Anaemia Intermediate Cycle II HLTM

    1/34

    Anaemia

    This material is intended to supportThis material is intended to support

    the didactic lecture series provided bythe didactic lecture series provided by

    The Department of Medicine forThe Department of Medicine forIntermediate Cycle IIIntermediate Cycle II

  • 8/3/2019 Anaemia Intermediate Cycle II HLTM

    2/34

    Learning Objectives

    At the end of this lecture you should be able to describe:At the end of this lecture you should be able to describe:

    Physiology of erythropoiesisPhysiology of erythropoiesis

    AnaemiaAnaemia

    DefinitionDefinition

    Clinical featuresClinical features

    InvestigationsInvestigations

    ClassificationClassification

  • 8/3/2019 Anaemia Intermediate Cycle II HLTM

    3/34

    Erythropoiesis

    25billion erythrocytes /24 hours25billion erythrocytes /24 hours

    The entering cells areThe entering cells are

    reticulocytes which should be 1%reticulocytes which should be 1%

    of the total population ofof the total population of

    circulating erythrocytes.circulating erythrocytes.

    Erythrocytes last 120days and areErythrocytes last 120days and are

    destroyed by the spleen.destroyed by the spleen.

    Red cell production should equalRed cell production should equal

    red cell destruction.red cell destruction.

  • 8/3/2019 Anaemia Intermediate Cycle II HLTM

    4/34

    Factors necessary for

    erythropoiesis

    1.1. ErythropoietinErythropoietin

    2.2. IronIron

    3.3. Amino acidsAmino acids

    4.4. Vitamin BVitamin B1212 (cyanocobalamin)(cyanocobalamin)

    5.5. Folic Acid(folate)Folic Acid(folate)

    6.6. Ascorbic acid(Vitamin C)Ascorbic acid(Vitamin C)

    7.7. Pyridoxine (Vitamin BPyridoxine (Vitamin B66))

  • 8/3/2019 Anaemia Intermediate Cycle II HLTM

    5/34

    Regulation of erythropoiesis

    Equal number of RBCEqual number of RBCproduced to thoseproduced to those

    lost throughlost throughsenescencesenescence

    Decreased delivery ofDecreased delivery ofoxygen to the kidneyoxygen to the kidneydrives Epodrives Epo

    production, whichproduction, whichstimulates RCCstimulates RCC

    production in theproduction in themarrowmarrow

  • 8/3/2019 Anaemia Intermediate Cycle II HLTM

    6/34

    Anaemia definition

    NB. Definition: reduction in one or more of the majorNB. Definition: reduction in one or more of the majorRBC measurementsRBC measurements

    Haemoglobin concentrationHaemoglobin concentration (HGB) =(HGB) = thetheconcentration of the major oxygenconcentration of the major oxygen--carryingcarryingpigment in whole blood.pigment in whole blood.

    HaematocritHaematocrit(HCT) =(HCT) = the percent of a sample ofthe percent of a sample ofwhole blood occupied by intact red blood cellswhole blood occupied by intact red blood cells

    RBC countRBC count== the number of red blood cellsthe number of red blood cellscontained in a specified volume of whole bloodcontained in a specified volume of whole blood

  • 8/3/2019 Anaemia Intermediate Cycle II HLTM

    7/34

    Anaemia WHO criteria

    BloodHGB below normalBloodHGB below normalrange for age and sexrange for age and sex

    MaleMale 13.013.0--------17.5g/dl17.5g/dl

    FemaleFemale 12.012.0--------16.0g/dl16.0g/dl

  • 8/3/2019 Anaemia Intermediate Cycle II HLTM

    8/34

    Anaemia- Clinical Features

    Signs and symptoms are dependent upon:Signs and symptoms are dependent upon:

    1.1. the degree of anaemiathe degree of anaemia

    2.2. the rate at which it has evolvedthe rate at which it has evolved

    3.3. the oxygen demands of thethe oxygen demands of the

    patientpatient decreased oxygen delivery,

    hypovolemia

  • 8/3/2019 Anaemia Intermediate Cycle II HLTM

    9/34

    Symptoms - Anaemia

    1.1. Lassitude /Lassitude /FatigueFatigue

    2.2. BreathlessnessBreathlessnesson exertionon exertion

    3.3. PalpitationsPalpitations4.4. Throbbing inThrobbing in

    head and earshead and ears5.5. DizzinessDizziness

    6.6. TinnitusTinnitus7.7. HeadacheHeadache8.8. Dimness ofDimness of

    visionvision9.9. InsomniaInsomnia10.10. ParaesthesiaParaesthesia

    e in fingerse in fingersand toesand toes

    11.11.AnginaAngina

  • 8/3/2019 Anaemia Intermediate Cycle II HLTM

    10/34

    Signs - Anaemia

    1.1. Pallor of Skin,Pallor of Skin,

    1. mucous membranes,

    2. Palmor creases

    3. conjuctivae

    2.2. TachycardiaTachycardia

    3.3. Cardiac dilatationCardiac dilatation-- displaced apex beatdisplaced apex beat

    4.4. Systolic Flow murmursSystolic Flow murmurs(due to dilatation of ventricle,(due to dilatation of ventricle,

    leading to mitral and tricuspid regurgitation)leading to mitral and tricuspid regurgitation)

    5.5. Angular stomatits/atrophic glossititsAngular stomatits/atrophic glossitits in iron deficiencyin iron deficiency

    or B12deficiencyor B12deficiency--related anaemiasrelated anaemias

  • 8/3/2019 Anaemia Intermediate Cycle II HLTM

    11/34

  • 8/3/2019 Anaemia Intermediate Cycle II HLTM

    12/34

    Clinical features of anaemia due to acute

    haemorrhage=features of

    hypovolemia!!!

    1.1. easy fatigabilityeasy fatigability2.2. muscle crampsmuscle cramps

    3.3. postural dizzinesspostural dizziness

    4.4. lethargylethargy5.5. syncopesyncope

    6.6. persistent hypotensionpersistent hypotension

  • 8/3/2019 Anaemia Intermediate Cycle II HLTM

    13/34

    Anaemia classifications

    A kinetic approachA kinetic approach

    A morphologic approachA morphologic approach

  • 8/3/2019 Anaemia Intermediate Cycle II HLTM

    14/34

    Anaemia - a kinetic

    approach

    1.1. Decreased RBC productionDecreased RBC production1. Lack of nutrients2. Bone marrow disorders

    3. Bone marrow suppression

    4. The anaemia of chronic disease/inflammation

    2.2. Increased RBC destructionIncreased RBC destruction1. Inherited haemolytic anemias

    2. Acquired haemolytic anemias3.3. Blood lossBlood loss

  • 8/3/2019 Anaemia Intermediate Cycle II HLTM

    15/34

    Anemia - morphologic

    approach

    Size of red cells

    MCV

    Uniform size or differing

    RDW

    Isolated anaemia or

    abnormal wcc/plts also

  • 8/3/2019 Anaemia Intermediate Cycle II HLTM

    16/34

    Anaemia- MCV

    1.1. MACROCYTIC > 100 fl (Large red cells)MACROCYTIC > 100 fl (Large red cells)

    2.2. NORMOCYTIC 80

    NORMOCYTIC 80--100

    fl (Normal size red100

    fl (Normal size redcells)cells)

    3.3. MICROCYTIC

  • 8/3/2019 Anaemia Intermediate Cycle II HLTM

    17/34

    Low MCV small RBC

    CommonCommon

    Iron DeficiencyIron DeficiencyNonNon--essential informationessential information

    1.1. FF -- ThalassaemiaThalassaemia

    2.2. Anaemia of Chronic DisorderAnaemia of Chronic Disorder3.3. Sideroblastic AnaemiaSideroblastic Anaemia

  • 8/3/2019 Anaemia Intermediate Cycle II HLTM

    18/34

    High MCV - macrocytic

    Core Causes

    B12 & Folate deficiency Alcohol

    Liver Disease

    Non-essential info

    Hypothyroidism

    Chemotherapy

    Haemolytic anaemia

  • 8/3/2019 Anaemia Intermediate Cycle II HLTM

    19/34

    Normal MCV - normocytic

    1. Anaemia of Chronic Disorders

    2. Early Iron Deficiency

    3. Anaemia due to acute haemorrhage

    Additional Info

    1. Combined Anaemia e.g. B12 deficency+ Fe deficiency

    2. Sideroblastic Anemia

    3. Aplastic Anemia

    4. Bone Marrow Infiltration

  • 8/3/2019 Anaemia Intermediate Cycle II HLTM

    20/34

    Systematic Approach to the

    evaluation of anemia

    History and Physical examinationHistory and Physical examination Fatigue, palpitations, SOB, headache Past medical history

    Medications

    Occupational history

    Social history

    Dietary history

    Family history

    History of blood loss (GI, Gynaecological)

    Pallor, jaundice, angular chelitis, koilonychia,

    s lenome al ,

  • 8/3/2019 Anaemia Intermediate Cycle II HLTM

    21/34

    Case 1

    BD, female, 75BD, female, 75

    Tiredness for more than 6/12Tiredness for more than 6/12

    Otherwise asymptomaticOtherwise asymptomatic

    PMHx: HE 34 years agoPMHx: HE 34 years ago

    (myomas; menorrhagia)(myomas; menorrhagia)

    HTN, well corrected on txHTN, well corrected on tx

    OsteoporosisOsteoporosis

  • 8/3/2019 Anaemia Intermediate Cycle II HLTM

    22/34

    Patient ResultsPatient Results Normal Range (Female)Normal Range (Female)

    HbHb 7.9 g/dl7.9 g/dl 11.711.7 -- 16.0g/dl16.0g/dl

    MCVMCV 62fl62fl 7979 -- 96 fl96 fl

    MCHMCH 19.0pg19.0pg 27.027.0 32.0pg32.0pg

    MCHCMCHC 30g/dl30g/dl 32.032.0 36.5g/dl36.5g/dl

    RDWRDW 19.219.2

    WBCWBC 5.3 x 105.3 x 1099/l/l 4.04.0-- 11.0x 1011.0x 1099/l/l

    PlateletsPlatelets 550x10550x1099/l/l 140140--450x 10450x 1099/l/l

    Case 1

  • 8/3/2019 Anaemia Intermediate Cycle II HLTM

    23/34

    Case 1

  • 8/3/2019 Anaemia Intermediate Cycle II HLTM

    24/34

    How to prove a lack ofiron???

  • 8/3/2019 Anaemia Intermediate Cycle II HLTM

    25/34

    Iron deficiency anaemia Iron

    studies

    Ferritin lowFerritin low

    Fe lowFe low Transferin saturation lowTransferin saturation low

    TBIC highTBIC high

  • 8/3/2019 Anaemia Intermediate Cycle II HLTM

    26/34

    Causes of Iron Deficiency

    Diet(vegetarians)Diet(vegetarians)

    MenorrhagiaMenorrhagia

    PregnancyPregnancy

    G.I.T. BleedG.I.T. BleedGrowth SpurtGrowth Spurt

    MalabsorptionMalabsorption

  • 8/3/2019 Anaemia Intermediate Cycle II HLTM

    27/34

    Treatment of Iron deficiency

    anaemia

    Iron replacement therapyIron replacement therapy

    (p.o., eventually i.v. if refractory)(p.o., eventually i.v. if refractory)

    Treatment of underlyingTreatment of underlying

    conditioncondition this is crucial,this is crucial,

    otherwise it will recur!!otherwise it will recur!!

  • 8/3/2019 Anaemia Intermediate Cycle II HLTM

    28/34

    Case 2

    DD, female, 48DD, female, 48

    Newly diagnosed with seroNewly diagnosed with sero--positive RApositive RA

    Medication: NSAIDMedication: NSAID

  • 8/3/2019 Anaemia Intermediate Cycle II HLTM

    29/34

    Patient ResultsPatient Results Normal Range (Male)Normal Range (Male)

    HbHb 9.8 g/dl9.8 g/dl 13.013.0-- 17.5g/dl17.5g/dl

    MCVMCV 78fl78fl 7979 -- 96 fl96 fl

    MCHMCH 26.026.0pgpg 27.027.0 32.0pg32.0pg

    MCHCMCHC 33 g/dl 33 g/dl 32.032.0 36.5g/dl36.5g/dl

    WBCWBC 9.2x 109.2x 1099/l/l 4.04.0-- 11.0x 1011.0x 1099/l/l

    lympholympho 0.7x0.7x101099/l/l 1.001.00--4.00x4.00x 101099/l/l

    PlateletPlatelet

    ss

    550x10550x1099/l/l 140140--450x 10450x 1099/l/l

    Case 2

  • 8/3/2019 Anaemia Intermediate Cycle II HLTM

    30/34

    Case 2

    Ferritin 344 ng/dL highFerritin 344 ng/dL high

    Fe 8 microg/mL lowFe 8 microg/mL low Transferin saturation 15% NTransferin saturation 15% N

    TBIC 150microg/dL lowTBIC 150microg/dL low

    ESR 68 mm/hESR 68 mm/h highhigh

    CRP 130mg/LCRP 130mg/L highhigh

  • 8/3/2019 Anaemia Intermediate Cycle II HLTM

    31/34

    Anaemia of chronic disorders

    Can be NormocyticCan be Normocytic--normochromic or microcyticnormochromic or microcytic--hypochromic,hypochromic,

    PathogenesisPathogenesis

    1.1. Low iron absorptionLow iron absorption

    2.2. inappropriate distribution of iron in bodyinappropriate distribution of iron in body

  • 8/3/2019 Anaemia Intermediate Cycle II HLTM

    32/34

    Anaemia of inflammation -

    pathophysiology

  • 8/3/2019 Anaemia Intermediate Cycle II HLTM

    33/34

    ACD - therapy

    Treat the underlying disorderTreat the underlying disorder

    Also can give erythropoietinAlso can give erythropoietinsupplementation to stimulatesupplementation to stimulate

    RCC productionRCC production

    EPO30EPO30--60.000units / week60.000units / week

  • 8/3/2019 Anaemia Intermediate Cycle II HLTM

    34/34

    Conclusion:

    anaemia is not a final diagnosis

    Characterize the anaemiaCharacterize the anaemia Confirm type of anaemiaConfirm type of anaemia

    Treat the anaemiaTreat the anaemia

    Find the underlying causeFind the underlying cause Treat the causeTreat the cause